Cargando…

Rapid rule-out of acute myocardial infarction at the emergency department with A troponin point of care testing in the COVID-19 era

INTRODUCTION: Emergency department (ED) investigations are time-consuming, mainly because of the turnaround time of laboratory assays. Furthermore, several reports showed that more extended emergency stays during the COVID-19 pandemic increase the likelihood of cross-infection. The introduction of t...

Descripción completa

Detalles Bibliográficos
Autores principales: Laouan Brem, F., Hammam, R., Bazid, Z., Nabila, I., Noha, E.O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Masson SAS 2023
Materias:
520
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9800766/
http://dx.doi.org/10.1016/j.acvdsp.2022.10.040
_version_ 1784861351492976640
author Laouan Brem, F.
Hammam, R.
Bazid, Z.
Nabila, I.
Noha, E.O.
author_facet Laouan Brem, F.
Hammam, R.
Bazid, Z.
Nabila, I.
Noha, E.O.
author_sort Laouan Brem, F.
collection PubMed
description INTRODUCTION: Emergency department (ED) investigations are time-consuming, mainly because of the turnaround time of laboratory assays. Furthermore, several reports showed that more extended emergency stays during the COVID-19 pandemic increase the likelihood of cross-infection. The introduction of troponin point of care assays with improved analytical precision and rapid availability of results compared to central laboratory testing reduces decision-making time in the ED to rule out AMI. OBJECTIVE: We aimed to compare the diagnostic performance of a troponin I POCT assay with a 10-minute turnaround time and the high sensitivity cardiac troponin (hs-cTn) performed in the laboratory. METHOD: A single-center observational cohort study carried out in adults’ patients presenting with non-traumatic chest pain suggestive of AMI at the ED of a tertiary hospital from Jul 29 to Sept 29, 2020. Troponin concentrations were measured on ED arrival and three (3) hours later with both a POCT assay (i-STAT CTnI; Abbott POC) and laboratory hs-cTnI assay (Architect hs-cTnI c8000). RESULTS: On admission and after 3 hours, both POCT and lab Hs-CTn showed the same sensitivity for diagnosing NSTEMI which was 93.8% and reached 100%. The negative predictive value (NPV) for POC CTnI was significantly higher than that for Lab Hs-Tn at 0 h (96.4% versus 95%). After 3 hours, both POCT and Lab Hs-Tn showed a NPV of 100%. Both assays showed higher AUC at 0 hour (POC TnI: 0.972 vs. lab Hs-Tn: 0.957). At 3 hour, the AUC for POC TnI was 0.996 and Lab Hs-Tn AUC was 0.998. (Fig. 1) The average length of hospital stay was 200 min for POCT vs. 464 min for hs-Lab (P < 0.001). CONCLUSION: The results our preliminary cohort suggest that in chest pain patients, the sensitivity of POC CTnI on admission and 3 hours later was comparable to that of the central lab hs-CTnI for ruling in and ruling out NSTEMI. Furthermore, after 3 hours of presenting to the ED, chest pain is not likely due to NSTEMI in patients with a negative POC CTnI assay. Therefore, patients could be safely discharged from the ED with a short emergency stay.
format Online
Article
Text
id pubmed-9800766
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Published by Elsevier Masson SAS
record_format MEDLINE/PubMed
spelling pubmed-98007662022-12-30 Rapid rule-out of acute myocardial infarction at the emergency department with A troponin point of care testing in the COVID-19 era Laouan Brem, F. Hammam, R. Bazid, Z. Nabila, I. Noha, E.O. Archives of Cardiovascular Diseases. Supplements 520 INTRODUCTION: Emergency department (ED) investigations are time-consuming, mainly because of the turnaround time of laboratory assays. Furthermore, several reports showed that more extended emergency stays during the COVID-19 pandemic increase the likelihood of cross-infection. The introduction of troponin point of care assays with improved analytical precision and rapid availability of results compared to central laboratory testing reduces decision-making time in the ED to rule out AMI. OBJECTIVE: We aimed to compare the diagnostic performance of a troponin I POCT assay with a 10-minute turnaround time and the high sensitivity cardiac troponin (hs-cTn) performed in the laboratory. METHOD: A single-center observational cohort study carried out in adults’ patients presenting with non-traumatic chest pain suggestive of AMI at the ED of a tertiary hospital from Jul 29 to Sept 29, 2020. Troponin concentrations were measured on ED arrival and three (3) hours later with both a POCT assay (i-STAT CTnI; Abbott POC) and laboratory hs-cTnI assay (Architect hs-cTnI c8000). RESULTS: On admission and after 3 hours, both POCT and lab Hs-CTn showed the same sensitivity for diagnosing NSTEMI which was 93.8% and reached 100%. The negative predictive value (NPV) for POC CTnI was significantly higher than that for Lab Hs-Tn at 0 h (96.4% versus 95%). After 3 hours, both POCT and Lab Hs-Tn showed a NPV of 100%. Both assays showed higher AUC at 0 hour (POC TnI: 0.972 vs. lab Hs-Tn: 0.957). At 3 hour, the AUC for POC TnI was 0.996 and Lab Hs-Tn AUC was 0.998. (Fig. 1) The average length of hospital stay was 200 min for POCT vs. 464 min for hs-Lab (P < 0.001). CONCLUSION: The results our preliminary cohort suggest that in chest pain patients, the sensitivity of POC CTnI on admission and 3 hours later was comparable to that of the central lab hs-CTnI for ruling in and ruling out NSTEMI. Furthermore, after 3 hours of presenting to the ED, chest pain is not likely due to NSTEMI in patients with a negative POC CTnI assay. Therefore, patients could be safely discharged from the ED with a short emergency stay. Published by Elsevier Masson SAS 2023-01 2022-12-30 /pmc/articles/PMC9800766/ http://dx.doi.org/10.1016/j.acvdsp.2022.10.040 Text en Copyright © 2022 Published by Elsevier Masson SAS. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle 520
Laouan Brem, F.
Hammam, R.
Bazid, Z.
Nabila, I.
Noha, E.O.
Rapid rule-out of acute myocardial infarction at the emergency department with A troponin point of care testing in the COVID-19 era
title Rapid rule-out of acute myocardial infarction at the emergency department with A troponin point of care testing in the COVID-19 era
title_full Rapid rule-out of acute myocardial infarction at the emergency department with A troponin point of care testing in the COVID-19 era
title_fullStr Rapid rule-out of acute myocardial infarction at the emergency department with A troponin point of care testing in the COVID-19 era
title_full_unstemmed Rapid rule-out of acute myocardial infarction at the emergency department with A troponin point of care testing in the COVID-19 era
title_short Rapid rule-out of acute myocardial infarction at the emergency department with A troponin point of care testing in the COVID-19 era
title_sort rapid rule-out of acute myocardial infarction at the emergency department with a troponin point of care testing in the covid-19 era
topic 520
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9800766/
http://dx.doi.org/10.1016/j.acvdsp.2022.10.040
work_keys_str_mv AT laouanbremf rapidruleoutofacutemyocardialinfarctionattheemergencydepartmentwithatroponinpointofcaretestinginthecovid19era
AT hammamr rapidruleoutofacutemyocardialinfarctionattheemergencydepartmentwithatroponinpointofcaretestinginthecovid19era
AT bazidz rapidruleoutofacutemyocardialinfarctionattheemergencydepartmentwithatroponinpointofcaretestinginthecovid19era
AT nabilai rapidruleoutofacutemyocardialinfarctionattheemergencydepartmentwithatroponinpointofcaretestinginthecovid19era
AT nohaeo rapidruleoutofacutemyocardialinfarctionattheemergencydepartmentwithatroponinpointofcaretestinginthecovid19era